Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Kedudukan dalam Saham
#4619
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Harga Saham
$3.20
Modal Pasaran
$3.24B
Perubahan (1 hari)
-2.37%
Perubahan (1 tahun)
-11.64%
Negara
CN
Perdagangan Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
Sejarah harga saham bagi Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Harga penutupan tertinggi: $3.15 pada 2026-10-01
Harga penutupan terendah: $0.24 pada 2008-07-01
Harga penutupan terendah: $0.24 pada 2008-07-01
Sejarah harga saham Jiangsu Nhwa Pharmaceutical Co., Ltd. dari 2008 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -7.86% |
| 2025 | 0.84% |
| 2024 | -6.47% |
| 2023 | 21.41% |
| 2022 | 29.91% |
| 2021 | -10.52% |
| 2020 | 65.99% |
| 2019 | 11.29% |
| 2018 | -34.33% |
| 2017 | 17.11% |
| 2016 | -13.62% |
| 2015 | 27.78% |
| 2014 | 21.35% |
| 2013 | 73.55% |
| 2012 | 33.53% |
| 2011 | -15.50% |
| 2010 | 63.69% |
| 2009 | 105.21% |
| 2008 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
